Sunburns, and all the symptoms that come with them, are not only unappealing, but also dangerous. While most of us know that getting sunburned increases our risk of developing skin cancer, and that it should be avoided, accidents do happen. And sometimes the resulting damage comes with side effects we don’t know how to handle. Natalie Curcio, MD, MPH, FAAD, a board-certified dermatologist practicing in Nashville, explains why our skin acts the way it does when it sustains a sunburn, and what we can do about it.
What Happens to Skin When It Gets Burned?
“A sunburn is a type of burn caused mainly by ultraviolet B radiation from the sun,” says Dr. Curcio. “It occurs after a body’s defenses are overwhelmed by too much exposure to this UV light. The toxic reaction that occurs is a sunburn.” Dr. Curcio says the extent of a sunburn depends on your skin type — people with fairer skin are at a higher risk for a serious sunburn — and the amount of exposure to UV rays you’ve received. First-degree sunburns can be red and painful to the touch, but affect only the epidermis, the outermost layer of the skin. Burns of this severity should heal within a few days. A second-degree sunburn is more serious. “These sunburns are severely red and make the skin swell up and blister,” says Dr. Curcio. “This means that the dermis (a deeper layer of skin) and nerve endings have been damaged. This type of sunburn will take longer to heal than a first-degree burn and will likely be more painful.” Unfortunately, both of these types of burns can start to peel (usually about three days after you sustain them). So what can you do to combat this?
When a Burn Takes a Turn
When skin begins to peel, it is a sign the body is trying to rid itself of damaged cells. You can use many of the same techniques that apply to a non-peeling sunburn to get some relief. Dr. Curcio says that getting out of the sun and treating a sunburn as soon as you notice it is the first step for healing sun-burned skin. “To relieve pain, you can take cold showers or baths and take ibuprofen or aspirin,” she says. “Also, the best thing to do is moisturize the area with an aloe-vera or soy-based product. Moisturizing will help soothe sunburned skin, but be careful to avoid petroleum-based or other oil-based creams. These may trap heat and make your sunburn even worse. In addition, don’t forget to drink extra water to prevent dehydration.” Once skin starts to peel, she adds, continue to moisturize your skin, which helps peeling skin heal faster. Be sure to take extra care to protect and cover peeling skin as it heals.
It may be tempting to try to exfoliate a peeling sunburn in an attempt to remove the dead skin, but Dr. Curcio says this isn’t a good idea. “Do not pull off your peeling skin, and avoid active exfoliation,” she says. “Instead, allow it to slough off your body on its own. Peeling usually stops when the burn has healed — about seven days for mild to moderate burns.” Finally, it’s imperative to practice effective sun protection while a peeling burn is healing. “After sustaining a sunburn, your skin is more sensitive to additional UV damage,” Dr. Curcio says. “Wear protective clothing that covers your skin when outdoors.”
In addition to covering up with clothing, you can seek shade and avoid peak sun hours (10 AM to 4 PM) to help you sidestep additional sun damage while your skin heals. If you take care of it and avoid additional sun exposure, a mild to moderate burn should heal in around seven days.
But the best way to avoid all this trouble is, you guessed it, avoiding sunburn in the first place. “Exposure to UV light is the most preventable risk factor for sunburn and for all skin cancers,” Dr. Curcio says. “Protect your skin from those harmful rays and always remember to wear a broad-spectrum sunscreen with an SPF 30 or higher!”
Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166: 1069–80.
Karjalainen S1, Salo H., Teppo L. Basal cell and squamous cell carcinoma of the skin in Finland. Site distribution and patientsurvival. Int J Dermatol. 1989 Sep; 28(7): 445–50.
Bastiaens MT, Hoefnagel JJ, Bruijn JA et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinoma indicate different types of tumors. J Invest Dermatol 1998; 110:880–4.
Luz FB, Ferron C., Cardoso GP. Surgical treatment of basal cell carcinoma: an algorithm based on the literature. An Bras Dermatol. 2015 May-Jun; 90(3): 377–83.
Julien Lanoue, Gary Goldenberg. Basal Cell Carcinoma, А Comprehensive Review of Existing and Emerging Nonsurgical Therapies. J Clin Aesthet Dermatol. 2016 May; 9 (5): 26–36.]
Vijlder, H., Sterenborg, H., Neumann, H., Robinson, D., Haas, E. (2012). Light Fractionation Significantly Improves the Response of Superficial Basal Cell Carcinoma to Aminolaevulinic Acid Photodynamic Therapy: Five-year Follow-up of a Randomized, Prospective Trial. Acta Dermato Venereologica, 92 (6), 641–647. doi: 10.2340/00015555-1448
Lehmann, P. (2007). Methyl aminolaevulinate?photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. British Journal of Dermatology, 156(5), 793–801. doi: 10.1111/j.1365-2133.2007.07833.x.
Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell carcinoma. Int J Dermatol. 2006 May; 45(5): 489–98.
Wysong, A., Aasi, S. Z., Tang, J. Y. (2013). Update on Metastatic Basal Cell Carcinoma: A Summary of Published Cases From 1981 Through 2011. JAMA Dermatology, 149(5), 615.
Sekulic A, Migden MR, Basset-Seguin N., Garbe C., Gesierich A., Lao CD., Miller C., Mortier L., Murrell DF., Hamid O., Quevedo JF., Hou J., McKenna E., Dimier N., Williams S., Schadendorf D., Hauschild A.; ERIVANCE BCC Investigators.Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: finalupdate of the pivotal ERIVANCE BCC study. BMC Cancer. 2017 May 16; 17(1):3 32. doi: 10.1186/s12885-017-3286-5.
Lear JT., Migden MR., Lewis KD., Chang ALS., Guminski A., Gutzmer R., Dirix L., Combemale P., Stratigos A., Plummer R., Castro H, Yi T., Mone M., Zhou J., Trefzer U., Kaatz M., Loquai C., Kudchadkar R., Sellami D., Dummer R. Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study.J Eur Acad Dermatol Venereol. 2018 Mar; 32 (3): 372–381. doi: 10.1111/jdv.14542. Epub 2017 Nov 6.
Wieman TJ., Shively EH., Woodcock TM. Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report. Cancer. N1983; 52 (9): 1583–1585.
Coker DD, Elias EG, Viravathana T, et al. Chemotherapy for metastatic basal cell carcinoma. Arch Dermatol. 1983; 119 (1): 44–50.
Guthrie TH., Jr, McElveen LJ., Porubsky ES., Harmon JD. Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer. 1985; 55 (8): 1629–1632.
Bason MM., Grant-Kels JM., Govil M. Metastatic basal cell carcinoma: response to chemotherapy. J Am Acad Dermatol. 1990; 22 (5 Pt 2): 905–908.
Khandekar JD. Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report of two patients. Arch Dermatol. 1990; 126 (12): 1,660.
Denic S. Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol. 1999; 22 (1): 32–34.
Jefford M., Kiffer JD., Somers G., et al. Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004; 74 (8): 704–705.
Moeholt K., Aagaard H., Pfeiffer P., Hansen O. Platinum-based cytotoxic therapy in basal cell carcinoma-a review of the literature. Acta Oncol. 1996; 35 (6): 677–682.
Carneiro BA., Watkin WG., Mehta UK., Brockstein BE. Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia. Cancer Invest. 2006; 24 (4): 396–400.